报告题目：Application of FDALabel Database to Advance Disease Study and drug development

报告人：Hong Fang，美国FDA高级研究员

主持人：石铁流 教授

报告时间：2018年9月28日 下午14:00—15:00

报告地点：生命科学学院534小会议室

 

报告人简介：Hong Fang博士1995年毕业于Missouri大学，长期从事化学信息学的研究工作，在FDA的毒理研究中心（NCTR）领导团队开发了广泛应用于FDA药物审批的FDALabel数据库，发表了近百篇相关的文章。

 

报告摘要：FDA approved drug labeling is the official description of a drug product approved by the FDA, it includes what the drug is used for, who should use it, side effects, instructions for use, and safety information, it provides comprehensive data from preclinical and clinical trials and updated with the post-market case reports (FAERS). Drug labeling represents the consensus and combined experience of regulators, drug manufacturers, and scientific experts. I will present why we built FDALabel database and how to better use the related information to guide the disease study and drug development.